Tumor-Microenvironment-Responsive Cell-Membrane-Coated Yolk-Shell Nanocomposites Enable Combination Therapy in Solid Tumors and Leukemia
ACS Applied Materials & Interfaces · 05.08.2026 · 18 (30) · 40353-40371
DOI: 10.1021/acsami.6c08325 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 13.07.2026. Verfasst von Tong Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Biological Science and Medical Engineering, Shanghai Engineering Research Center of Nano-Biomaterials and Regenerative Medicine, Donghua U…. Hauptthemen laut MEDLINE: Nanocomposites, Tumor Microenvironment, Leukemia, Cell Membrane. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben.
Abstract (Originalsprache)
Conventional chemotherapeutic agents are frequently limited by off-target toxicity and suboptimal therapeutic outcomes. Nanomedicines utilizing cell membrane camouflage provide a promising strategy for precise drug delivery and multimodal combination therapy. Herein, we designed a tumor-microenvironment-responsive cell-membrane-coated nanocomposite (designated as ZnO2@MO-D@Mn-CeO2@CM), which consists of a zinc peroxide (ZnO2) core encapsulated within a drug-loaded mesoporous organosilica (MO-D, where D is doxorubicin for the 4T1 breast cancer model and daunorubicin for the C1498 leukemia model) layer, with the mesopores gated by manganese-doped cerium oxide (Mn-CeO2) nanoparticles, and coated with a homologous cell membrane (CM). This nanocomposite enables the release of therapeutic components under acidic conditions and in the presence of elevated glutathione (GSH). It facilitates a combination therapy by integrating chemotherapy, enhanced chemodynamic therapy (CDT), ferroptosis induction, and immunomodulation. Our results demonstrate that this nanocomposite effectively suppresses the progression in 4T1 solid tumor and C1498 leukemia models, demonstrating its potential as a robust combinatorial strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Biological Science and Medical Engineering, Shanghai Engineering Research Center of Nano-Biomaterials and Regenerative Medicine, Donghua University, Shanghai201620, PR China.
- Hongqiao International Institute of Medicine, Shanghai Tongren Hospital/Faculty of Basic Medicine, Key Laboratory of Cell Differentiation and Apoptosis of the Chinese Ministry of Education, Shanghai Jiao Tong University…
ORCID-Profile: Limin Zhu
Zitieren
APA
Wang, T., Wang, Y., Xu, J., Zheng, Y., Zhang, Y., Wu, Y., & Zhu, L. (2026). Tumor-Microenvironment-Responsive Cell-Membrane-Coated Yolk-Shell Nanocomposites Enable Combination Therapy in Solid Tumors and Leukemia. ACS Applied Materials & Interfaces, 18(30), 40353-40371. https://doi.org/10.1021/acsami.6c08325
Vancouver
Wang T, Wang Y, Xu J, Zheng Y, Zhang Y, Wu Y, et al. Tumor-Microenvironment-Responsive Cell-Membrane-Coated Yolk-Shell Nanocomposites Enable Combination Therapy in Solid Tumors and Leukemia. ACS Applied Materials & Interfaces. 2026;18(30):40353-40371. doi:10.1021/acsami.6c08325
BibTeX
@article{Wang2026,
author = {Wang, Tong and Wang, Yingying and Xu, Jianxiang and Zheng, Yilu and Zhang, Yanyan and Wu, Yingli and Zhu, Limin},
title = {Tumor-Microenvironment-Responsive Cell-Membrane-Coated Yolk-Shell Nanocomposites Enable Combination Therapy in Solid Tumors and Leukemia},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
volume = {18},
number = {30},
pages = {40353--40371},
doi = {10.1021/acsami.6c08325}
}
EUVIMED